Clinical relevance of mutant NPM1 and CEBPA in patients with acute myeloid leukaemia – preliminary report

AIM OF THE STUDY: Mutant NPM1 and CEBPA have been reported in patients with acute myeloid leukaemia (AML) and intermediate cytogenetic risk, and they appear to be associated with characteristic demographic and laboratory data, as well as clinical outcome. The objective of the study was to assess the...

Descripción completa

Detalles Bibliográficos
Autores principales: Helbig, Grzegorz, Wozniczka, Krzysztof, Wieclawek, Agnieszka, Soja, Anna, Bartkowska-Chrobok, Aleksandra, Kyrcz-Krzemien, Slawomira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2014
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171470/
https://www.ncbi.nlm.nih.gov/pubmed/25258581
http://dx.doi.org/10.5114/wo.2014.43490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171470/
https://www.ncbi.nlm.nih.gov/pubmed/25258581
http://dx.doi.org/10.5114/wo.2014.43490

Ejemplares similares